ES2098948T3 - Procedimientos de ensayo de analogos de acido nucleico. - Google Patents

Procedimientos de ensayo de analogos de acido nucleico.

Info

Publication number
ES2098948T3
ES2098948T3 ES94916331T ES94916331T ES2098948T3 ES 2098948 T3 ES2098948 T3 ES 2098948T3 ES 94916331 T ES94916331 T ES 94916331T ES 94916331 T ES94916331 T ES 94916331T ES 2098948 T3 ES2098948 T3 ES 2098948T3
Authority
ES
Spain
Prior art keywords
nucleic acid
acid analog
amount
test procedures
analog test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94916331T
Other languages
English (en)
Inventor
Christopher John Stanley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PNA Diagnostics ApS Denmark
Original Assignee
PNA Diagnostics ApS Denmark
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PNA Diagnostics ApS Denmark filed Critical PNA Diagnostics ApS Denmark
Application granted granted Critical
Publication of ES2098948T3 publication Critical patent/ES2098948T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

UN PROCEDIMIENTO DE ENSAYO PARA CUANTIFICAR LA CANTIDAD DE UNA MUESTRA INICIADORA EN UN PROCEDIMIENTO DE AMPLIFICACION DE ACIDO NUCLEICO TAL COMO PCR QUE INVOLUCRA INTENTAR LA AMPLIFICACION EN LA PRESENCIA DE VARIAS CANTIDADES DE UN ANALOGO DE UN ACIDO NUCLEICO EN SUFICIENTE CANTIDAD PARA INHIBIR DICHO PROCEDIMIENTO DE AMPLIFICACION MEDIANTE LA INTERACCION SELECTIVA CON ESPECIES DE ACIDO NUCLEICO PRESENTES, POR EJEMPLO UN PNA COMO DESCRITO EN WO-02-20703. LA CANTIDAD DE LA MUESTRA ES DADA POR LA CANTIDAD DEL ANALOGO DE ACIDO NUCLEICO QUE ES CRITICO PARA CAUSAR EL FALLO DE DICHO PROCEDIMIENTO DE AMPLIFICACION.
ES94916331T 1993-06-02 1994-05-31 Procedimientos de ensayo de analogos de acido nucleico. Expired - Lifetime ES2098948T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939311386A GB9311386D0 (en) 1993-06-02 1993-06-02 Nucleic acid analogue assay procedures

Publications (1)

Publication Number Publication Date
ES2098948T3 true ES2098948T3 (es) 1997-05-01

Family

ID=10736511

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94916331T Expired - Lifetime ES2098948T3 (es) 1993-06-02 1994-05-31 Procedimientos de ensayo de analogos de acido nucleico.

Country Status (9)

Country Link
US (1) US5912145A (es)
EP (1) EP0701627B1 (es)
JP (1) JP2842694B2 (es)
AU (1) AU6802994A (es)
DE (1) DE69401661T2 (es)
DK (1) DK0701627T3 (es)
ES (1) ES2098948T3 (es)
GB (1) GB9311386D0 (es)
WO (1) WO1994028171A1 (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629178A (en) * 1994-10-28 1997-05-13 Genetics & Ivf Institute Method for enhancing amplification in the polymerase chain reaction employing peptide nucleic acid (PNA)
EP0826066B1 (en) 1995-05-05 2000-09-13 The Perkin-Elmer Corporation Methods and reagents for combined pcr amplification and hybridization probing assay
US5939262A (en) 1996-07-03 1999-08-17 Ambion, Inc. Ribonuclease resistant RNA preparation and utilization
US5677124A (en) * 1996-07-03 1997-10-14 Ambion, Inc. Ribonuclease resistant viral RNA standards
US6617422B1 (en) 1997-05-23 2003-09-09 Peter Nielsen Peptide nucleic acid monomers and oligomers
US6485901B1 (en) 1997-10-27 2002-11-26 Boston Probes, Inc. Methods, kits and compositions pertaining to linear beacons
DK1471926T3 (da) 1999-06-01 2011-02-28 Baylor College Medicine Sammensætninger og fremgangsmåder til terapeutisk anvendelse af en atonal-associeret sekvens
WO2001051669A2 (en) * 2000-01-15 2001-07-19 Genelabs Technologies, Inc. Nucleic acid binding assay and selection method
EP3415625A1 (en) 2002-02-01 2018-12-19 Life Technologies Corporation Double-stranded oligonucleotides
WO2003064621A2 (en) 2002-02-01 2003-08-07 Ambion, Inc. HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
US20030211483A1 (en) * 2002-05-09 2003-11-13 Schroeder Benjamin G. Methods for the enrichment of low-abundance polynucleotides
EP2269619A1 (en) 2002-08-12 2011-01-05 Jennerex Biotherapeutics ULC Methods and compositions concerning poxviruses and cancer
ES2345993T3 (es) 2004-09-14 2010-10-07 The Regents Of The University Of Colorado, A Body Corporate Metodo para el tratamiento con bucindolol basado en direccionamiento genetico.
CA2842402C (en) 2005-03-10 2016-02-23 Gen-Probe Incorporated Systems and methods to perform assays for detecting or quantifying analytes within samples
CN101351213B (zh) * 2005-09-07 2013-10-02 詹纳里克斯公司 使用表达gm-csf的痘病毒系统性治疗转移性癌和/或全身散布性癌
US8980246B2 (en) 2005-09-07 2015-03-17 Sillajen Biotherapeutics, Inc. Oncolytic vaccinia virus cancer therapy
DE602007006478D1 (de) 2006-05-12 2010-06-24 Cepheid Sunnyvale Erkennung der verbindung einer dna-rekombination
CN102026645B (zh) 2006-09-15 2016-01-27 渥太华医院研究机构 溶瘤弹状病毒
US20100129902A1 (en) * 2008-11-24 2010-05-27 Erhard Ralf Schoenbrunner Replication Stable and RNase Resistant Chimeras of Pestivirus with Insertion in 3' Nontranslated Region (3'NTR)
JP5785942B2 (ja) 2009-06-29 2015-09-30 ルミネックス コーポレーション ヘアピンコンフォメーションを有するキメラプライマーおよびその使用法
US9409983B2 (en) 2009-07-23 2016-08-09 The Board Of Trustess Of The University Of Illinois Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
WO2011032088A1 (en) 2009-09-11 2011-03-17 Arca Biopharma, Inc. Polymorphisms in the pde3a gene
ES2671570T3 (es) 2009-09-14 2018-06-07 Sillajen Biotherapeutics, Inc. Terapia combinada contra el cáncer con virus oncolítico de vaccinia
WO2011070440A2 (en) 2009-12-10 2011-06-16 Ottawa Hospital Research Institute Oncolytic rhabdovirus
WO2011079273A2 (en) 2009-12-23 2011-06-30 Arca Biopharma, Inc. Methods and compositions for cardiovascular diseases and conditions
CN103429258B (zh) 2011-01-04 2016-03-09 新罗杰公司 通过施用溶瘤痘苗病毒生成针对肿瘤抗原的抗体和生成肿瘤特异性补体依赖性细胞毒性
MX2013009863A (es) 2011-02-28 2013-12-06 Univ Iowa Res Found Cambios de la hormona anti-mulleriana en el embarazo y prediccion de sexo y de resultados adversos en el embarazo.
AU2012226530B2 (en) 2011-03-08 2016-12-01 King Abdullah University Of Science And Technology Molecular biomarker set for early detection of ovarian cancer
US9364532B2 (en) 2011-06-08 2016-06-14 Children's Hospital Of Eastern Ontario Research Institute Inc. Compositions and methods for glioblastoma treatment
US10040853B2 (en) 2011-09-09 2018-08-07 Fred Hutchinson Cancer Research Center Methods and compositions involving NKG2D inhibitors and cancer
US10125373B2 (en) 2013-01-22 2018-11-13 Arizona Board Of Regents On Behalf Of Arizona State University Geminiviral vector for expression of rituximab
JP2016513115A (ja) 2013-02-21 2016-05-12 チルドレンズ ホスピタル オブ イースタン オンタリオ リサーチ インスティチュート インコーポレイテッド ワクチン組成物
AU2014329535B2 (en) 2013-10-03 2017-09-07 Oklahoma Medical Research Foundation Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
CN106103431B (zh) 2014-01-10 2019-03-15 葛兰素史密斯克莱知识产权（第2 号）有限公司 羟基甲酰胺衍生物及其用途
GB201411567D0 (en) * 2014-06-30 2014-08-13 Epistem Ltd Quantification methods
EP3224362B1 (en) 2014-11-26 2024-09-25 The Regents of The University of California Therapeutic compositions comprising transcription factors and methods of making and using the same
WO2018140606A1 (en) 2017-01-26 2018-08-02 Oklahoma Medical Research Foundation Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
US12140592B2 (en) 2017-06-16 2024-11-12 Oklahoma Medical Research Foundation Biomarkers for assessing risk of transitioning to systemic lupus erythematosus classification and disease pathogenesis
US20210349088A1 (en) 2018-10-18 2021-11-11 Oklahoma Medical Research Foundation Biomarkers For A Systemic Lupus Erythematosus (SLE) Disease Activity Immune Index That Characterizes Disease Activity
US12510539B2 (en) 2018-10-18 2025-12-30 Progentec Diagnostics, Inc. Biomarkers for a systemic lupus erythematosus (SLE) disease activity immune index that characterizes disease activity
ES2975662T3 (es) 2018-10-31 2024-07-11 Univ Arizona Biomarcadores y métodos de uso para la lesión pulmonar inducida por radiación
WO2021055489A1 (en) 2019-09-16 2021-03-25 Grohar Patrick J Compositions and methods for the treatment of swi-snf mutant tumors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219727A (en) * 1989-08-21 1993-06-15 Hoffmann-Laroche Inc. Quantitation of nucleic acids using the polymerase chain reaction
GB9016163D0 (en) * 1990-07-24 1990-09-05 Cemu Bioteknik Chemical method
DK51092D0 (da) * 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
GB9211979D0 (en) * 1992-06-05 1992-07-15 Buchard Ole Uses of nucleic acid analogues

Also Published As

Publication number Publication date
DE69401661D1 (de) 1997-03-13
EP0701627B1 (en) 1997-01-29
US5912145A (en) 1999-06-15
DE69401661T2 (de) 1997-06-12
EP0701627A1 (en) 1996-03-20
DK0701627T3 (da) 1997-07-21
AU6802994A (en) 1994-12-20
JPH08510384A (ja) 1996-11-05
GB9311386D0 (en) 1993-07-21
WO1994028171A1 (en) 1994-12-08
JP2842694B2 (ja) 1999-01-06

Similar Documents

Publication Publication Date Title
ES8405072A1 (es) Un procedimiento para la preparacion de un vector de trans- ferencia dna
ES2126626T3 (es) Tecnicas para preparar especimenes para ensayos bacterianos.
BR9805900A (pt) Processo para integrar um fragmento de dna no genoma de uma c-lula de uma planta manocot¡ledonea e composi-Æo para o meio de crescimento de plantas
ES2040199T3 (es) Proceso para controlar la contaminacion de reacciones de amplificacion de acidos nucleicos.
GT197746150A (es) Nuevos agentes antielminticos y proceso para su prepracion
MX9300766A (es) Piridonas sustituidas por sulfonilbencilo, procedimiento para su obtencion y medicamentos que las contienen.
ES2069571T3 (es) Proceso de desnitrificacion biologica.
ES8507177A1 (es) Un metodo para detectar bacterias en una muestra a ensayar
ES2084582T3 (es) Utilizacion de un elemento regulador anaerobico en plantas.
ES2058299T3 (es) Metodo de extraer atp.
DE69530001D1 (de) Verbesserungen von oder in bezug auf endometrialfunktion
BR0108212A (pt) Agente e processo para tingimento de fibras de queratina
ES2173194T3 (es) Procedimiento de racemizacion utilizado para la preparacion de levobupivacaina y sus analogos.
ES2090026T3 (es) Dispositivo para intensificar la fluorescencia y cineticas y metodos para utilizar el dispositivo.
ES2096973T3 (es) Fosfazenos que contienen radicales organicos de silicio, proceso para su preparacion, y su empleo.
ES2084637T3 (es) Procedimiento para la inactivacion biologica de acidos nucleicos.
ES8701734A1 (es) Un procedimiento para preparar hidantoinas opticamente acti-vas
ES2037032T3 (es) Procedimiento para detectar un analito asi como agente apropiado para ello.
ES2056108T3 (es) Empleo de interacciones anticuerpo/antigeno para proteger o modular la actividad biologica.
ES2059311T3 (es) Extraccion de sustancias de ensayo.
ES2062256T3 (es) Procedimiento para producir amida de acido alfa-hidroxiisobutirico.
ES2083840T3 (es) Suspensiones acuosas estables de zeolitas, su procedimiento de obtencion y su utilizacion.
ES2160572T3 (es) Un metodo para el tratamiento de lana.
ES2166773T3 (es) Medio selectivo y procedimiento para la enumeracion de las bacterias propionicas.
ES2173178T3 (es) Composicion catalitica mcm-22 mejorada.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 701627

Country of ref document: ES